| VARIABLES |
IRAQI PATIENTS AGE / Years (%) 20-34 35-49 50-64 = / > 65 |
Total | P Value | |||
|---|---|---|---|---|---|---|
| STAGE | 19 (3.6)* | 250 (47.5) | 219 (41.6) | 38 (7.2) | 526 | - |
| I | 1 (5.3)** | 32 (12.8) | 25 (11.4) | 5 (13.2) | 63 | 0.4248 |
| II | 8 (42.1) | 111 (44.4) | 117 (53.4) | 14 (36.8) | 250 | |
| III | 9 (47.4) | 86 (34.4) | 58 (26.5) | 15 (39.5) | 168 | |
| IV | 1 (5.3) | 21 (8.4) | 19 (8.7) | 4 (10.5) | 45 | |
| TUMOR SIZE | 28 (4.7) | 283 (47.8) | 241 (40.7) | 40 (6.8) | 592 | - |
| T1 | 6 (21.4) | 56 (19.8) | 49 (20.3) | 9 (22.5) | 120 | 0.2207 |
| T2 | 12 (42.9) | 163 (57.6) | 148 (61.4) | 28 (70) | 351 | |
| T3 | 9 (32.1) | 49 (17.3) | 34 (14.1) | 2 (5.0) | 94 | |
| T4 | 1 (3.6) | 15 (5.3) | 10 (4.1) | 1 (2.5) | 27 | |
| LYMPH NODE | 24 (4.1) | 279 (48) | 240 (41.3) | 38 (6.5) | 581 | - |
| N0 | 4 (16.7) | 86 (30.8) | 83 (34.6) | 11 (28.9) | 184 | 0 .0095 |
| N1 | 8 (33.3) | 85 (30.5) | 84 (35) | 8 (21.1) | 185 | |
| N2 | 3 (12.5) | 70 (25.1) | 44 (18.3) | 9 (23.7) | 126 | |
| N3 | 9 (37.5) | 38 (13.6) | 29 (12.1) | 10 (26.3) | 86 | |
| ER STATUS | 25 (4.5) | 265 (47.2) | 234 (41.7) | 37 (6.6) | 561 | - |
| ER Positive | 19 (76) | 170 (64.2) | 172 (73.5) | 27 (73) | 388 | 0 .1121 |
| ER Negative | 6 (24) | 95 (35.8) | 62 (26.5) | 10 (37) | 173 | |
| PR STATUS | 25 (4.5) | 266 (47.4) | 233 (41.5) | 37 (6.6) | 561 | - |
| PR Positive | 14 (56) | 168 (63.2) | 167 (71.7) | 25 (67.6) | 374 | 0 .1449 |
| ER Negative | 11 (44) | 98 (36.8) | 66 (32.3) | 12 (32.4) | 187 | |
| HER2 STATUS | 24 (4.4) | 260 (48.1) | 220 (40.7) | 37 (6.8) | 541 | - |
| HER2 Positive | 12 (50) | 74 (28.5) | 59 (26.8) | 13 (35.1) | 158 |
0.0968 |
| HER2 Negative | 12 (50) | 186 (71.5) | 161 (73.2) | 24 (64.9) | 383 | |
| SUBTYPES | 19 (4.1) | 222 (48.3) | 186 (40.4) | 33 (7.2) | 460 | - |
| Luminal A | 8 (42.1) | 112 (50.5) | 114 (61.3) | 18 (54.5) | 252 | 0.2296 |
| Luminal B | 5 (26.3) | 35 (15.8) | 27 (14.5) | 6 (18.2) | 73 | |
| HER2 Enriched | 3 (15.8) | 26 (11.7) | 24 (12.9) | 4 (12.1) | 57 | |
| Triple Negative | 3 (15.8) | 49 (22.1) | 21 (11.3) | 5 (15.2) | 78 | |